Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: A matched case analysis
    Journal Article

    Moss, N. S.; Singh, J. M.; Reiner, A. S.; Drago, J. Z.; Modi, S.; Seidman, A. D.; Chandarlapaty, S.; Ross, D. S.
    npj Breast Cancer (2023)

    Fulltext@MSK | Save
  • A randomized controlled trial testing a virtual program for Asian American women breast cancer survivors
    Journal Article

    Im, E. O.; Chee, W.; Paul, S.; Choi, M. Y.; Kim, S. Y.; Deatrick, J. A.; Inouye, J.; Ma, G.; Meghani, S.; Nguyen, G. T.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Financial toxicity monitoring in a randomized controlled trial of patient-reported outcomes during cancer treatment (Alliance AFT-39)
    Journal Article

    Blinder, V. S.; Deal, A. M.; Ginos, B.; Jansen, J.; Dueck, A. C.; Mazza, G. L.; Henson, S.; Carr, P.; Rogak, L. J.; Weiss, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • New strategies for the treatment of breast cancer with leptomeningeal metastasis
    Review

    Chew, S. M.; Seidman, A. D.
    Current Opinion in Oncology (2023)

    Fulltext@MSK | Save
  • Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer
    Journal Article

    Kim, S.; Armand, J.; Safonov, A.; Zhang, M.; Soni, R. K.; Schwartz, G.; McGuinness, J. E.; Hibshoosh, H.; Razavi, P.; Kim, M.; more...
    Cell Reports (2023)

    Fulltext@MSK | Save
  • Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: Outcomes and biomarker analysis from the SUMMIT trial
    Journal Article

    Jhaveri, K.; Eli, L. D.; Wildiers, H.; Hurvitz, S. A.; Guerrero-Zotano, A.; Unni, N.; Brufsky, A.; Park, H.; Waisman, J.; Yang, E. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
    Meeting Abstract

    Harbeck, N.; Boileau, J. F.; Modi, S.; Kelly, C.; Ohno, S.; Wu, J.; Konpa, A.; Herbolsheimer, P.; Safdar, S.; Zhang, Y.; more...
    Breast (2023)

    Fulltext@MSK | Save
  • BRCA mutational status is associated with higher rate of pathologic complete response in hormone receptor-positive breast cancer
    Meeting Abstract

    Myers, S. P.; Walsh, E. M.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
    Journal Article

    Morra, A.; Schreurs, M. A. C.; Andrulis, I. L.; Anton-Culver, H.; Augustinsson, A.; Beckmann, M. W.; Behrens, S.; Bojesen, S. E.; Bolla, M. K.; Brauch, H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • New frontiers in the role of locoregional therapies in breast cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel
    Editorial

    Daye, D.; Panagides, J.; Norton, L.; Ahmed, M.; Fukuma, E.; Ward, R. C.; Gomez, D.; Kokabi, N.; Vogl, T.; Abi-Jaoudeh, N.; more...
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save